Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Bioanalysis|August 18, 2020
European Immunogenicity Platform 11th Open Scientific Symposium on immunogenicity of biopharmaceuticalsSophie Tourdot, Carolina B Quaglia, Paul Chamberlain, et al.
Cureus|June 12, 2018
Utilizing Light-field Imaging Technology in NeurosurgeryBrian R Chen, Ian A Buchanan, Spencer Kellis, et al.
Mabs|July 9, 2021
Challenges of non-clinical safety testing for biologics: A Report of the 9th BioSafe European Annual General Membership MeetingThomas Kissner, Guenter Blaich, Andreas Baumann, et al.
BMC Cancer|January 17, 2013
A phase 1b study of humanized KS-interleukin-2 (huKS-IL2) immunocytokine with cyclophosphamide in patients with EpCAM-positive advanced solid tumorsJoseph P Connor, Mihaela C Cristea, Nancy L Lewis, et al.
Journal of Neural Engineering|October 5, 2019
A benchtop system to assess the feasibility of a fully independent and implantable brain-machine interfacePo T Wang, Everardo Camacho, Ming Wang, et al.
Addictive Behaviors Reports|June 1, 2026
Recruitment feasibility for deep brain stimulation compared to transcranial magnetic stimulation treatment trials for methamphetamine use disorderJoseph Sakai, Jody Tanabe, Kristen Raymond, et al.
Vaccine|November 14, 2020
Safety biomarkers for development of vaccines and biologics: Report from the safety biomarkers symposium held on November 28-29, 2017, Marcy l'Etoile, FranceMichel Doubovetzky, Yasemin Ataman-Önal, Benjamin Chousterman, et al.
Bioanalysis|January 19, 2018
Feedback from the European Bioanalysis Forum: focus workshop on current analysis of immunogenicity: best practices and regulatory hurdlesJoanne Goodman, Simon Cowen, Viswanath Devanarayan, et al.
Optics Express|February 25, 2022
Large area ion beam sputtered dielectric ultrafast mirrors for petawatt laser beamlinesThomas Willemsen, Uddhab Chaulagain, Irena Havlíčková, et al.
Frontiers in Surgery|April 17, 2023
Postsurgical morbidity and mortality favorably informs deep brain stimulation for new indications including schizophrenia and schizoaffective disorderJudith M Gault, Patrick Hosokawa, Daniel Kramer, et al.
Pageof 7